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SUMMARY 
Several studies in West have indicated that clonidine hydrochloride, an adrenergic blocking agent is both 
safe and effective for detoxifying nacrotic addicts. One hundred and two patients of opium addition admitted in 
Psychiatry Cente Jodhpur were subjects for present study. The patients were divided into group A, B and C hav-
ing thirty four in each group. These groups were identical with regards to sociodemographic variables, mean dose 
of opium and duration of intake. Group A was given clonidine in small doses, Group B symptomatic therapy and 
group C was given clonidine in high doses. Study was double blind. Record of blood pressure, pulse rate, other 
vital sign and withdrawal symptom (on Physician's Rating Scale) was kept twice daily, Treatment was continued 
for two weeks. Clonidine in high doses proved to be more effective than other therapies. 
Drag addiction exists is some form or 
the other in almost every country of the 
world. The reasons for drug addiction may 
be economical, physical, mental and cul-
tural besides individual and social differ-
ences. 
Opium addiction is the commonset 
addiction in western Rajasthan, Punjab 
and some parts of Madhya Pradesh. 
Opium is considered to be a powerful nar-
cotic and owes its activity chiefly due to 
morphine, an alkaloid present in it. Many 
individual get to know of opium through 
association, group pressure and personal 
interests and find in them a sensation of 
pleasure and well being particularly in the 
initial phase. They then try again and again 
to recapture that sensation and thus de-
velop dependence. Opium dependence has 
created many psychological problems by ad-
versely influencing the physical health, earn-
ing capacity and interpersonal relationship. 
Due to non availability and high cost of 
opium and knowledge about its treatability, 
increasing number of addicts are visiting our 
centre for detoxification. Some of 
them on their own tried to leave opium, but 
could not do so, because of painful with-
drawal symptoms. In fact control of with-
drawal symptoms plays a vital role in the 
management of opium dependent patients. 
The mechanism of opiate with-
drawal symptoms is due to (Gold et al. 
1978) increased nor adrenergic activity 
caused by the released inhibited activity 
of locus coeruleus and release of depre-
ssed transmission of spinal sympathetic 
preganglionic neurons. There are 
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several approaches to tackle this 
problem -
1. To modify euphoria and withdrawal 
symptom by giving drugs that act on 
neurotransmitters. This has not been 
found successful. 
2. Replacement by methadone. This 
method is slow and difficult one and 
there are potentials for abuse and with-
drawal symptoms. 
3. Others - beta adrenergic antagonists -
propranolol, the alpha adrenergic an-
tagonists, neuroleptics and nor ad-
renergic synthesis inhibitors. They all 
decrease nor adrenergic function. 
In the last group, clonidine, a im-
idazolidine, an alpha adrenergic agonist 
has been proved to be safe and effective 
agent for detoxifying narcotic addicts. 
Studies on rodent and primates (Gold 
et al. 1980) suggest that neurotransmitter 
nor adrenaline is involved in opiate with-
drawal. Clonidine acts by inhibition of nor 
adrenergic activity via other inhibitory re-
ceptors on these neurons, catecholamine 
synthesis inhibition or by post synaptic 
blockage of noradrenergic projection area. 
In Western countries, opiate addicts 
are primarily managed by replacing it by 
methadone (Gold et al. 1978). In some 
studies methadone has been replaced by 
clonidine with good results (Gold et al. 
1978 and 1980). Doses varying from 6 figm 
- 16/igm/kg body weight has been used. 
In India not much attention has been 
paid regarding the management of drug 
addicts and opium addicts are treated by 
symptomatic therapy. However, in few 
studies clonidine (Gehlot et al. 1984, Sub-
ramanya and Channabasavanna, 1981) 
and DiPhenxylate and Proxyphene (Gur-
meet Singh et al. 1984) have been given. 
There is hardly any study available in 
India which has critically evaluated the 
effectiveness of clonidine in opium addict 
and compared its efficacy with symptoma-
tic therapy and therefore the present study 
was planned to evaluate the effectiveness 
of clonidine in opiate detoxification and 
compare it with symptomatic therapy. 
Material and Methods 
Sample: The subjects of this study 
were 102 opium addicts who were admit-
ted in Psychiatric Centre Jodhpur during 
the period between January 86 to June 86. 
Diagnosis of drug addiction was made as 
per LCD. 9 criteria. Functional and 
organic psychotic conditions were 
excluded. Also patients with current use of 
mono amino-oxidase inhibitors, neurolep-
tics, sedatives hypnotics, anti hypertensive 
drugs within two weeks of begining of 
therapy, current alcohol abuse,allergy to 
imidazolidine drugs, any medical diseases 
like chronic cardiac disorder, renal, 
metabolic diseases, moderate to severe 
hypertension were not taken. 
Procedure 
All the subjects were male and they 
were divided into group A, B and C (34 pa-
tients in each group). Age range, mean 
dose of opium, duration of intake is given 
in Table 1. Thus these three groups were 
identical with regard to age, dose and du-
ration of opium intake. 
A physical examination and approp-
riate medical evaluation was performed 
for each case before the start of therapy. 
Opium was withdrawn suddenly in all pa-
tients by the turkey method. 
Pharmacotherapy 
Group A was given clonidine (small 
dose) .lmg on the 1st day and gradually in-
creased to .5mg - .6mg during next 3-5 days. 
This dose is maintained during next 10 days. D.C. SATIAETAL. 
Table 1 
Characteristics of the 3 Groups of Patients 
under study of opium withdrawl 
Name of 
Group 
Group A 
(Low dose 
clonidine 
therapy) 
Group B 
(Sympto-
matic therapy) 
Group C 
(High dose 
clonidine 
therapy) 
Total 
No. of Pts. 
34 
34 
34 
No. of 
Pts. 
Abscon-
ded 
2 
2 
0 
No. of pts. 
dropped 
out 
2 
2 
4 
No. of pts. Age range Mean Age Mean dose Mean 
completed (in years) (in years) of opium Duration of 
therapy (in gms) intake 
(in years) 
30 
30 
30 
21-65 30.2 14.5 4.5 
20-64 30.5 14.4 4.7 
25-61 31.2 14.2 4.6 
Group B was given symptomatic 
therapy which included chlorpromazine 
(150 mg/day), Nitrazepam (lOmg bed 
time), antiemetics, analgesics and other 
symptomatic therapy as needed. Group C 
was given clonidine (high doses) 0.5mg to* 
start with and increased to lmg - 1.2mg/ 
day till symptoms were controlled. Phar-
macotherapy in the three groups was given 
for 2 weeks and the patients were hos-
pitalised for 3 weeks. No attendants were 
allowed to meet the patients and close 
watch was kept so that no drug or opium 
was smuggled inside. 
Evaluation: Each patient was 
examined in the morning and evening and 
record of blood pressure, pulse rate and 
other vital signs was kept regularly just 
prior to and one hour after each drug ad-
ministration. Withdrawal symptoms were 
recorded independently by Psychiatrist 
who completed Withdrawal Symptoms 
Rating Scale having 24 items by giving 0 to 
no symptoms and 3 to severe symptoms 
(Methodology used by Charney S. Dennis 
et al. 1980). The drugs were given in identi-
cal capsules and patients and evaluating 
doctor did not know about the drugs pa-
tient was taking. 
Assessment of somatic and 
psychological side effects and analysis of 
severity of withdrawal symptoms were 
done on Symptoms Rating Scale. 
Discussion 
Opium withdrawal is reported to be 
associated with intolerable symptoms of 
palpitation, restlessness, muscular and 
joint pain, insomnia, anorexia yawning 
etc. These symptoms discourage the ad-
dicts not to leave opium. 
In western countries, opium addicts 
are being treated with methadone replace-
ment therapy. Experience has shown that 
this process is slow and difficult one and 
also there are potentials for its abuse (Gold 
et al. 1978). 
It is seen in this study that low doses of 
clonidine as well as symptomatic therpay 
influence the withdrawal symptoms of 
opium but clonidine in high doses was 
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Table 2 
Mean and S.D. of each symptom on 
clonidine low dose therapy in controlling 
withdrawal symptoms of opium at the end of 
I & II weeks on physician rating scale using 'T test 
Table 3 
Mean and S.D. of each symptom by symptomatic 
therapy in controlling opium withdrawal 
symptoms in I and II week of therapy 
Symptom  I Week 
M  S.D. 
II Week 
M S.D. 
Significance 
P 
Symptoms 
I Week 
(N=30) 
Mean S.D. 
II Week 
(N = 30) 
Mean S.D. 
Significance 
P 
Loss of 
appetite 
Sweating 
Difficulty in 
Sleeping 
Chills 
Hot flashes 
Nervousness 
Low energy 
Irritability 
Stomach 
cramp 
Nausea 
Vomiting 
Feeling 'Blah' 
Diarrhoea 
Joint pain 
Muscle pain 
Tremor 
Drowsiness 
Running nose 
Tearing 
Craving 
Yawning 
Drymouth 
Sneezing 
Palpitation 
31.3 
29.4 
41.7 
18.6 
29.6 
30.8 
43.9 
30.3 
11.88 
11.8 
13.3 
23.9 
8.3 
33.2 
37.9 
6.8 
20.9 
: 23.3 
13.9 
18.7 
28.6 
18.3 
24.4 
31.3 
9.6 
5.8 
8.27 
6.4 
9.5 
6.7 
9.61 
13.2 
3.1 
2.7 
2.6 
8.3 
3.3 
5.8 
5.6 
2.3 
9.6 
7.4 
3.9 
5.3 
6.74 
4.7 
6.3 
11.6 
30.02 
21.8 
39.98 
17.8 
28.3 
31.9 
41.78 
31.8 
6.4 
8.3 
11.8 
24.2 
6.4 
28.8 
23.6 
2.3 
8.4 
20.2 
10.4 
16.1 
26.9 
16.4 
21.2 
29.1 
6.6 
9.9 
12.77 
8.4 
11.72 
9.6 
12.69 
10.6 
2.2 
1.6 
2.7 
6.6 
2.28 
9.2 
8.9 
1.1 
3.5 
8.3 
2.8 
2.7 
4.8 
3.8 
3.7 
6.6 
N.S. 
<0.05 
N.S. 
N.S. 
N.S. 
N.S. 
N.S. 
N.S. 
<0.01 
<0.05 
<0.05 
N.S. 
<0.05 
<0.05 
<0.05 
<0.01 
<0.01 
<0.05 
<0.05 
<0.05 
N.S. 
<0.05 
<0.05 
<0.05 
Loss of 
appetite 
Sweating 
Difficulty 
in Sleeping 
Chills 
Hot flushes 
Nervousness 
Low energy 
Irritability 
Stomach 
Cramps 
Nausea 
Vomiting 
Feeling'Blah' 
Diarrhoea 
Joint Pain 
Muscle Pain 
Tremors 
Drowsiness 
Running 
nose 
Tearing 
Craving 
Yawning 
Dry mouth 
Sneezing 
Palpitation 
38.6 
20.8 
41.0 
21.6 
29.4 
38.6 
40.6 
34.4 
13.0 
11.6 
10.4 
20.4 
5.4 
45.0 
47.2 
7.0 
23.2 
26.0 
23.8 
11.4 
38.8 
22.0 
31.0 
22.4 
7.6 
6.4 
10.5 
5.3 
5.2 
7.6 
7.2 
6.6 
2.8 
4.6 
6.6 
6.3 
3.2 
7.5 
9.3 
1.2 
6.9 
4.4 
9.4 
3.7 
4.8 
1.7 
6.6 
3.6 
39.1 
19.6 
39.0 
20.4 
8.4 
37.9 
38.9 
32.9 
4.8 
10.8 
9.3 
19.2 
4.6 
18.8 
19.6 
1.6 
9.1 
24.6 
22.1 
12.8 
32.1 
13.4 
29.4 
19.2 
8.7 
6.7 
13.6 
6.3 
9.9 
9.9 
11.7 
8.8 
5.11 
4.8 
3.8 
2.6 
2.6 
4.2 
5.4 
1.9 
5.4 
12.8 
10.8 
2.9 
14.8 
5.8 
11.4 
6.2 
N.S. 
N.S. 
<0.5 
N.S. 
<0.01 
N.S. 
N.S. 
N.S. 
<0.01 
N.S. 
N.S. 
N.S. 
N.S. 
<0.01 
<0.01 
<0.01 
<0.01 
N.S. 
N.S. 
N.S. 
N.S. 
<0.05 
N.S. 
<0.05 
regarding the control of severity of with-
drawal symptoms and its duration. When 
we made the comparison of each symptom 
of clonidine low dose therapy in control-
ling withdrawal symptoms at the end of 1st 
and 2nd week on Symptom Rating Scale 
with that of high dose therapy, we found 
that significant differences emerged on 15 
symptoms out of 24 in the former, whereas 
significant difference were found in all 
these symptoms with high dose therapy. 
Furthermore, all these differences were 
significant at .01 level in comparison to low 
dose therapy where significant difference 
emerged only for 3 symptoms. In sympto-
matic therapy significant difference were 
found on 9 symptoms and 6 were signific-
ant at .01 level. On the basis of these statis-
tical analysis we can safely infer that 
clonidine given in high dose is far superior 
to low dose clonidine and symptomatic 
therapy in controlling withdrawal 
symptoms of opium. 
Twenty six patients (86%) with high 
doses and eight (27.5%) patients on low 
doses of clonidine developed hypotension 
and associated tachycardia. None of the 
patients required any specific therapy to 
control it. D.C. SATIAETAL.  59 
Table 4 
Mean and S.D. of each symptom on clonidine high 
dose therapy in controlling withdrawal symptoms of 
opium at the end of I and II week 
I Week „ „ II Week orN  Symptom w S.D. w S.D.  Mean Mean 
Loss of 
appetite 
Sweating 
Difficulty in 
sleeping 
Chills 
Hot flushes 
Nervousness 
Low energy 
Irritability 
Stomach 
cramp 
Nausea 
Vomiting 
Feeling 'Blah' 
Diarrhoea 
Joint Pain 
Muscle pain 
Tremor 
Drowsiness 
Running 
nose 
Tearing 
Craving 
Yawning 
Dry mouth 
Sneezing 
Palpiration 
38.4 
23.0 
46.6 
22.0 
27.0 
40.6 
44.8 
37.8 
15.2 
19.2 
12.6 
31.6 
10.4 
47.8 
50.8 
6.6 
27.8 
30.8 
30.8 
8.2 
41.0 
27.2 
32.3 
20.6 
6.1 
5.3 
11.3 
5.0 
5.1 
10.5 
11.1 
8.4 
5.2 
7.0 
6.1 
11.2 
3.7 
10.2 
9.8 
2.4 
8.3 
7.3 
7.3 
2.7 
6.8 
5.7 
6.0 
3.2 
16.0 
4.0 
21.0 
5.2 
10.4 
12.6 
14.4 
11.6 
4.2 
4.6 
3.0 
19.4 
1.6 
21.8 
19.6 
2.4 
7.2 
8.6 
8.6 
0.8 
14.8 
7.6 
16.4 
8.4 
11.5 
2.9 
12.9 
4.4 
3.8 
9.8 
10.5 
8.5 
3.2 
4.9 
3.7 
12.8 
1.8 
14.2 
12.1 
1.5 
5.7 
6.3 
6.M3 
1.0 
8.4 
4.7 
8.1 
5.5 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
<0.01 
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